JP2011526283A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011526283A5 JP2011526283A5 JP2011516575A JP2011516575A JP2011526283A5 JP 2011526283 A5 JP2011526283 A5 JP 2011526283A5 JP 2011516575 A JP2011516575 A JP 2011516575A JP 2011516575 A JP2011516575 A JP 2011516575A JP 2011526283 A5 JP2011526283 A5 JP 2011526283A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- conr
- coor
- formula
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 15
- 125000001424 substituent group Chemical group 0.000 claims 10
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 8
- 241000124008 Mammalia Species 0.000 claims 8
- 230000000840 anti-viral effect Effects 0.000 claims 8
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 7
- 125000000217 alkyl group Chemical group 0.000 claims 6
- 229910052736 halogen Inorganic materials 0.000 claims 6
- 150000002367 halogens Chemical class 0.000 claims 6
- 125000001072 heteroaryl group Chemical group 0.000 claims 6
- 229910052739 hydrogen Inorganic materials 0.000 claims 6
- 239000008194 pharmaceutical composition Substances 0.000 claims 6
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims 5
- 208000030507 AIDS Diseases 0.000 claims 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 5
- 229910052799 carbon Inorganic materials 0.000 claims 5
- 239000003085 diluting agent Substances 0.000 claims 5
- 239000003937 drug carrier Substances 0.000 claims 5
- 239000000546 pharmaceutical excipient Substances 0.000 claims 5
- 125000000753 cycloalkyl group Chemical group 0.000 claims 4
- 208000015181 infectious disease Diseases 0.000 claims 4
- 229910052757 nitrogen Inorganic materials 0.000 claims 4
- 229910052760 oxygen Inorganic materials 0.000 claims 4
- 239000001301 oxygen Substances 0.000 claims 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 4
- 125000004434 sulfur atom Chemical group 0.000 claims 4
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 claims 3
- 208000031886 HIV Infections Diseases 0.000 claims 3
- 208000037357 HIV infectious disease Diseases 0.000 claims 3
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 claims 3
- 238000000034 method Methods 0.000 claims 3
- 229910052717 sulfur Inorganic materials 0.000 claims 3
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical group [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims 2
- 230000002924 anti-infective effect Effects 0.000 claims 2
- 229960005475 antiinfective agent Drugs 0.000 claims 2
- 239000003443 antiviral agent Substances 0.000 claims 2
- 239000003054 catalyst Substances 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 125000002541 furyl group Chemical group 0.000 claims 2
- 239000002835 hiv fusion inhibitor Substances 0.000 claims 2
- 125000002883 imidazolyl group Chemical group 0.000 claims 2
- 239000002955 immunomodulating agent Substances 0.000 claims 2
- 229940121354 immunomodulator Drugs 0.000 claims 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 2
- 125000001715 oxadiazolyl group Chemical group 0.000 claims 2
- 125000003373 pyrazinyl group Chemical group 0.000 claims 2
- 125000003226 pyrazolyl group Chemical group 0.000 claims 2
- 125000002098 pyridazinyl group Chemical group 0.000 claims 2
- 125000004076 pyridyl group Chemical group 0.000 claims 2
- 125000000714 pyrimidinyl group Chemical group 0.000 claims 2
- 125000003831 tetrazolyl group Chemical group 0.000 claims 2
- 229940124597 therapeutic agent Drugs 0.000 claims 2
- 125000001113 thiadiazolyl group Chemical group 0.000 claims 2
- 125000000335 thiazolyl group Chemical group 0.000 claims 2
- 125000001544 thienyl group Chemical group 0.000 claims 2
- 125000001425 triazolyl group Chemical group 0.000 claims 2
- 229940126154 HIV entry inhibitor Drugs 0.000 claims 1
- 239000012317 TBTU Substances 0.000 claims 1
- CLZISMQKJZCZDN-UHFFFAOYSA-N [benzotriazol-1-yloxy(dimethylamino)methylidene]-dimethylazanium Chemical compound C1=CC=C2N(OC(N(C)C)=[N+](C)C)N=NC2=C1 CLZISMQKJZCZDN-UHFFFAOYSA-N 0.000 claims 1
- -1 antiinfectives Substances 0.000 claims 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 1
- 239000003153 chemical reaction reagent Substances 0.000 claims 1
- 230000002584 immunomodulator Effects 0.000 claims 1
- 229910052763 palladium Inorganic materials 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7537408P | 2008-06-25 | 2008-06-25 | |
| US61/075,374 | 2008-06-25 | ||
| PCT/US2009/048427 WO2009158394A1 (en) | 2008-06-25 | 2009-06-24 | Diketo azolopiperidines and azolopiperazines as anti-hiv agents |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011526283A JP2011526283A (ja) | 2011-10-06 |
| JP2011526283A5 true JP2011526283A5 (enExample) | 2012-07-26 |
| JP5433690B2 JP5433690B2 (ja) | 2014-03-05 |
Family
ID=41137086
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011516575A Expired - Fee Related JP5433690B2 (ja) | 2008-06-25 | 2009-06-24 | 抗−ｈｉｖ薬としてのジケト縮合アゾロピペリジンおよびアゾロピペラジン |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US7960406B2 (enExample) |
| EP (1) | EP2303876B1 (enExample) |
| JP (1) | JP5433690B2 (enExample) |
| CN (1) | CN102131810B (enExample) |
| ES (1) | ES2462403T3 (enExample) |
| WO (1) | WO2009158394A1 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7579510B2 (en) | 2006-02-03 | 2009-08-25 | Grt, Inc. | Continuous process for converting natural gas to liquid hydrocarbons |
| EP2696937B1 (en) * | 2011-04-12 | 2017-05-17 | VIIV Healthcare UK (No.5) Limited | Thioamide, amidoxime and amidrazone derivatives as hiv attachment inhibitors |
| ES2616268T3 (es) | 2011-08-29 | 2017-06-12 | VIIV Healthcare UK (No.5) Limited | Derivados condensados de diamina bicíclica como inhibidores de la unión de VIH |
| PT2807153T (pt) | 2012-01-25 | 2020-06-18 | Novartis Ag | Compostos heterocíclicos e métodos para seu uso |
| BR112014019289A8 (pt) | 2012-02-08 | 2017-07-11 | Bristol Myers Squibb Co | Métodos para a preparação do composto de prome-dicamento de piperazina inibidor da ligação do hiv |
| JO3407B1 (ar) | 2012-05-31 | 2019-10-20 | Eisai R&D Man Co Ltd | مركبات رباعي هيدرو بيرازولو بيريميدين |
| ES2616432T3 (es) * | 2012-08-09 | 2017-06-13 | VIIV Healthcare UK (No.5) Limited | Derivados de alquenos tricíclicos como inhibidores de la unión del VIH |
| CN105283455B (zh) * | 2013-03-27 | 2017-06-16 | 百时美施贵宝公司 | 作为hiv吸附抑制剂的2‑酮基酰胺衍生物 |
| EP2978762A1 (en) * | 2013-03-27 | 2016-02-03 | Bristol-Myers Squibb Company | Piperazine and homopiperazine derivatives as hiv attachment inhibitors |
| GB201321748D0 (en) | 2013-12-09 | 2014-01-22 | Ucb Pharma Sa | Therapeutic agents |
| PT3233853T (pt) * | 2014-12-18 | 2019-05-27 | Viiv Healthcare Uk No 4 Ltd | Processo para preparar compostos de azaindole halogenados utilizando boroxina |
| US20170362262A1 (en) * | 2014-12-18 | 2017-12-21 | ViiV Healthcare UK (No.4) Limited | A process for preparing halogenated azaindole compounds using pybrop |
| US9550779B2 (en) * | 2014-12-30 | 2017-01-24 | Novira Therapeutics, Inc. | Derivatives and methods of treating hepatitis B infections |
| US10153966B1 (en) * | 2015-03-12 | 2018-12-11 | Alarm.Com Incorporated | Hybrid mesh network monitoring signaling environment |
| KR102708936B1 (ko) | 2015-11-20 | 2024-09-25 | 포르마 세라퓨틱스 인크. | 유비퀴틴-특이적 프로테아제 1 억제제로서의 퓨리논 |
| EP3464286B1 (en) * | 2016-05-24 | 2021-08-18 | Genentech, Inc. | Pyrazolopyridine derivatives for the treatment of cancer |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4354924A (en) * | 1980-06-25 | 1982-10-19 | Chevron Research Company | Dual component chromia silicate cracking catalyst |
| US4812462A (en) * | 1986-04-01 | 1989-03-14 | Warner-Lambert Company | 4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine-6-carboxylic acid analogs having antihypertensive activity |
| US6469006B1 (en) | 1999-06-15 | 2002-10-22 | Bristol-Myers Squibb Company | Antiviral indoleoxoacetyl piperazine derivatives |
| US6476034B2 (en) | 2000-02-22 | 2002-11-05 | Bristol-Myers Squibb Company | Antiviral azaindole derivatives |
| US6573262B2 (en) | 2000-07-10 | 2003-06-03 | Bristol-Myers Sqibb Company | Composition and antiviral activity of substituted indoleoxoacetic piperazine derivatives |
| KR20030079979A (ko) | 2001-02-02 | 2003-10-10 | 브리스톨-마이어스스퀴브컴파니 | 치환된 아자인돌옥소아세틱 피페라진 유도체의 조성물 및항바이러스 활성 |
| US20040110785A1 (en) | 2001-02-02 | 2004-06-10 | Tao Wang | Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives |
| US6825201B2 (en) | 2001-04-25 | 2004-11-30 | Bristol-Myers Squibb Company | Indole, azaindole and related heterocyclic amidopiperazine derivatives |
| US20030236277A1 (en) | 2002-02-14 | 2003-12-25 | Kadow John F. | Indole, azaindole and related heterocyclic pyrrolidine derivatives |
| US7348337B2 (en) * | 2002-05-28 | 2008-03-25 | Bristol-Myers Squibb Company | Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides |
| US20040063744A1 (en) | 2002-05-28 | 2004-04-01 | Tao Wang | Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides |
| US20040106104A1 (en) | 2002-06-11 | 2004-06-03 | Pin-Fang Lin | Viral envelope mediated fusion assay |
| US6900206B2 (en) | 2002-06-20 | 2005-05-31 | Bristol-Myers Squibb Company | Indole, azaindole and related heterocyclic sulfonylureido piperazine derivatives |
| US20040063746A1 (en) | 2002-07-25 | 2004-04-01 | Alicia Regueiro-Ren | Indole, azaindole and related heterocyclic ureido and thioureido piperazine derivatives |
| AU2003290647A1 (en) | 2002-11-08 | 2004-06-03 | Bristol-Myers Squibb Company | Pharmaceutical compositions and methods of using taxane derivatives |
| US20050075364A1 (en) | 2003-07-01 | 2005-04-07 | Kap-Sun Yeung | Indole, azaindole and related heterocyclic N-substituted piperazine derivatives |
| OA13235A (en) | 2003-08-14 | 2006-12-13 | Pfizer | Piperazine derivatives for the treatment of HIV infections. |
| US7745625B2 (en) | 2004-03-15 | 2010-06-29 | Bristol-Myers Squibb Company | Prodrugs of piperazine and substituted piperidine antiviral agents |
| US20050215544A1 (en) | 2004-03-24 | 2005-09-29 | Pin-Fang Lin | Methods of treating HIV infection |
| US20050215543A1 (en) | 2004-03-24 | 2005-09-29 | Pin-Fang Lin | Methods of treating HIV infection |
| US7776863B2 (en) | 2004-03-24 | 2010-08-17 | Bristol-Myers Squibb Company | Methods of treating HIV infection |
| DE102004020908A1 (de) * | 2004-04-28 | 2005-11-17 | Grünenthal GmbH | Substituierte 5,6,7,8,-Tetrahydro-pyrido[4,3-d]pyrimidin-2-yl- und 5,6,7,8,-Tetrahydro-chinazolin-2-yl-Verbindungen |
| US7449476B2 (en) | 2004-05-26 | 2008-11-11 | Bristol-Myers Squibb Company | Tetrahydrocarboline antiviral agents |
| WO2005121094A1 (en) | 2004-06-09 | 2005-12-22 | Pfizer Limited | Piperazine and piperidine derivatives as anti-hiv-agents |
| US7396830B2 (en) | 2005-10-04 | 2008-07-08 | Bristol-Myers Squibb Company | Piperazine amidines as antiviral agents |
| US7851476B2 (en) | 2005-12-14 | 2010-12-14 | Bristol-Myers Squibb Company | Crystalline forms of 1-benzoyl-4-[2-[4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-YL)-1-[(phosphonooxy)methyl]-1H-pyrrolo[2,3-C]pyridin-3-YL]-1,2-dioxoethyl]-piperazine |
| US20070259879A1 (en) | 2006-03-06 | 2007-11-08 | Trimeris, Inc. | Piperazine and piperidine biaryl derivatives |
| US7807671B2 (en) * | 2006-04-25 | 2010-10-05 | Bristol-Myers Squibb Company | Diketo-piperazine and piperidine derivatives as antiviral agents |
| US7504399B2 (en) | 2006-06-08 | 2009-03-17 | Bristol-Meyers Squibb Company | Piperazine enamines as antiviral agents |
-
2009
- 2009-06-24 WO PCT/US2009/048427 patent/WO2009158394A1/en not_active Ceased
- 2009-06-24 CN CN200980133292.3A patent/CN102131810B/zh not_active Expired - Fee Related
- 2009-06-24 ES ES09770927.3T patent/ES2462403T3/es active Active
- 2009-06-24 JP JP2011516575A patent/JP5433690B2/ja not_active Expired - Fee Related
- 2009-06-24 EP EP09770927.3A patent/EP2303876B1/en not_active Not-in-force
- 2009-06-24 US US12/490,714 patent/US7960406B2/en active Active
-
2011
- 2011-05-05 US US13/101,591 patent/US8124615B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011526283A5 (enExample) | ||
| JP2011526286A5 (enExample) | ||
| JP2011528658A5 (enExample) | ||
| JP2013510124A5 (enExample) | ||
| JP2016516043A5 (enExample) | ||
| JP2013510120A5 (enExample) | ||
| JP2019532928A5 (enExample) | ||
| JP2013507425A5 (enExample) | ||
| JP2010524932A5 (enExample) | ||
| JP2014508811A5 (enExample) | ||
| CA2637765A1 (en) | Benzamide and heteroarene derivatives | |
| JP2010241830A5 (enExample) | ||
| JP2011037841A5 (enExample) | ||
| JP2009530345A5 (enExample) | ||
| JP2014503574A5 (enExample) | ||
| IL200923A0 (en) | 1-(1-benzylpiperidin-4-yl)benzimidazole-5-carboxylic acid derivatives for the treatment of diabetes mellitus | |
| TW200833663A (en) | Therapeutic agents | |
| JP2013542261A5 (enExample) | ||
| JP2009519243A5 (enExample) | ||
| JP2016190843A5 (enExample) | ||
| JP2011509302A5 (enExample) | ||
| JP2013514980A5 (enExample) | ||
| JP2018529690A5 (enExample) | ||
| EP2621491B1 (en) | 2-pyridone antimicrobial compositions | |
| JP2012515195A5 (enExample) |